Pharmagen, Inc.
Pharmagen, Inc. (PHRX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
phrx · pe ratio · data through Dec 31, 2013
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Pharmagen, Inc. (PHRX) measures how much investors pay for each dollar of the company's trailing earnings. PHRX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Source: FMP · /ratios-ttm · /analyst-estimates · 2013-12-31
PE Ratio History
2013 – 2013 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pharmagen, Inc.You PHRX | $0M | N/A | — | -$0.02 |
 Aequus Pharmaceuticals Inc. AQSZF | $0M | N/A | — | -$0.02 |
 BioLife Sciences Inc. BLFE | $0M | N/A | — | -$0.02 |
 Banyan Corp. BNYN | $0M | N/A | — | -$17.79 |
 Electromedical Technologies, Inc. EMED | $0M | N/A | — | -$0.00 |
 Invion Limited IVIXF | $0M | N/A | — | -$0.08 |
 Rimrock Gold Corp. RMRK | $0M | 6.78x | — | $0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2013-12-31Latest FY2013 | — | $-0.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pharmagen, Inc. (PHRX) measures how much investors pay for each dollar of the company's trailing earnings. PHRX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Frequently asked questions
PHRX pe ratio · 6 questionsPHRX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via PHRX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pharmagen, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09